InvestSMART

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Announcements

- Current share price for NSB : $0.060

ASX company news and announcements for NeuroScientific Biopharmaceuticals Ltd (NSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All NeuroScientific Biopharmaceuticals Ltd (NSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than NeuroScientific Biopharmaceuticals Ltd (NSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for NeuroScientific Biopharmaceuticals Ltd (NSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Notice of Annual General Meeting 2 Oct 2024 3:53PM $0.039 $0.060 risen by 53.85%
$23 Appendix 4G & Corporate Governance Statement 29 Aug 2024 7:21PM $0.042 $0.060 risen by 42.86%
$23 2024 Annual Report & Appendix 4E 29 Aug 2024 7:21PM $0.042 $0.060 risen by 42.86%
$23 Quarterly Activities/Appendix 4C Cash Flow Report 19 Jul 2024 9:43AM $0.040 $0.060 risen by 50%
$23 Notice of Release of Escrowed Securities 10 Jul 2024 1:06PM $0.038 $0.060 risen by 57.89%
$23 NSB Completes PRE-IND Meeting with US FDA on EmtinB 11 Jun 2024 9:15AM $0.047 $0.060 risen by 27.66%
$23 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2024 8:52AM $0.048 $0.060 risen by 25%
$23 Notification of cessation of securities - NSB 8 Apr 2024 12:04PM $0.065 $0.060 fallen by 7.69%
$23 Appointment of Executive Director & FDA Pre-Ind Meeting 2 Apr 2024 9:26AM $0.047 $0.060 risen by 27.66%
$23 NSB Receives A$2.2M Research & Development Tax Refund 20 Mar 2024 9:39AM $0.047 $0.060 risen by 27.66%
$23 Half Yearly Report and Accounts 27 Feb 2024 5:43PM $0.035 $0.060 risen by 71.43%
$23 Company Secretary Appointment/Resignation 6 Feb 2024 9:52AM $0.037 $0.060 risen by 62.16%
$23 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2024 9:55AM $0.035 $0.060 risen by 71.43%
$23 Notification of cessation of securities - NSB 15 Jan 2024 3:35PM $0.039 $0.060 risen by 53.85%
$23 Expiry of Options 27 Dec 2023 5:21PM $0.040 $0.060 risen by 50%
$23 Final Director's Interest Notice - Rennie 7 Dec 2023 1:11PM $0.051 $0.060 risen by 17.65%
$23 Final Director's Interest Notice - Quantrill 5 Dec 2023 7:50PM $0.050 $0.060 risen by 20%
$23 Initial Director's Interest Notice - Keating 5 Dec 2023 7:45PM $0.050 $0.060 risen by 20%
$23 Changes to NSB Board 5 Dec 2023 10:32AM $0.050 $0.060 risen by 20%
$23 Resignation of CEO 1 Dec 2023 12:11PM $0.071 $0.060 fallen by 15.49%
$23 Results of Meeting 30 Nov 2023 4:59PM $0.071 $0.060 fallen by 15.49%
$23 Chair's address to shareholders & AGM presentation 30 Nov 2023 2:38PM $0.071 $0.060 fallen by 15.49%
$23 Notice of Annual General Meeting - Withdrawal of Resolutions 27 Nov 2023 6:43PM $0.071 $0.060 fallen by 15.49%
$23 Initial Director's Interest Notice - Barlow 21 Nov 2023 11:50AM $0.057 $0.060 risen by 5.26%
$23 Initial Director's Interest Notice - Ntoumenopoulos 21 Nov 2023 11:46AM $0.057 $0.060 risen by 5.26%

76 - 100 of 409 results

Page 4 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.